¹⁸F-FDG-PET ALS的认知障碍相关

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.

ALS中心(a . Canosa点,双性恋五厘米、人工智能,:,A. Calvo, A. Chiò), “Rita Levi Montalcini” Department of Neuroscience, University of Turin; Department of Neurosciences, Ophthalmology, Genetics, Rehabilitation and Child Health (A. Canosa), University of Genoa; Institute of Cognitive Sciences and Technologies (M.P., A. Cistaro, A. Chiò), C.N.R., Rome, Italy; Department of Nuclear Medicine (M.P.), Karolinska Hospital, Stockholm, Sweden; Positron Emission Tomography Centre IRMET S.p.A. (A. Cistaro, P.F.), EuroMedic International, Turin; Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino (A. Calvo, A. Chiò), Turin; and the Neuroscience Institute of Turin (NIT) (A. Calvo, A. Chiò), Italy.